Overview
Ruoping Tang practices practicing medicine in Paris, France.
Tang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Chronic T-Cell Leukemia (CTCL), and Prolymphocytic Leukemia.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ruoping Tang
Is Ruoping Tang a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Ruoping Tang is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ruoping Tang participate in research or clinical trials?
Yes. Ruoping Tang has published 21 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Ruoping Tang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- Experienced
- Chronic T-Cell Leukemia (CTCL)
- LeukemiaTang isExperienced. Learn about Leukemia.
- Prolymphocytic LeukemiaTang isExperienced. Learn about Prolymphocytic Leukemia.